Robert Redfield

14.8k total citations · 1 hit paper
160 papers, 5.4k citations indexed

About

Robert Redfield is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Robert Redfield has authored 160 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Infectious Diseases, 81 papers in Virology and 30 papers in Immunology. Recurrent topics in Robert Redfield's work include HIV Research and Treatment (81 papers), HIV/AIDS drug development and treatment (60 papers) and HIV/AIDS Research and Interventions (39 papers). Robert Redfield is often cited by papers focused on HIV Research and Treatment (81 papers), HIV/AIDS drug development and treatment (60 papers) and HIV/AIDS Research and Interventions (39 papers). Robert Redfield collaborates with scholars based in United States, Nigeria and Canada. Robert Redfield's co-authors include Anthony S. Fauci, Brett P. Giroir, Donald S. Burke, Alonso Heredia, Charles E. Davis, N L Michael, Nhut Le, Maryanne Vahey, Gideon Sjoberg and Mohammad M. Sajadi and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert Redfield

153 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ending the HIV Epidemic

2019 1.0k citations Anthony S. Fauci, Robert Redfield et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert Redfield	2.4k	1.7k	1.5k	791	682	160	5.4k
Robert R. Redfield	2.8k 1.1×	3.8k 2.2×	2.2k 1.5×	290 0.4×	2.8k 4.0×	188	10.0k
Graham Hart	4.7k 1.9×	634 0.4×	4.2k 2.8×	2.6k 3.3×	274 0.4×	303	11.0k
John L. Sullivan	7.8k 3.2×	3.7k 2.2×	2.8k 1.8×	1.3k 1.7×	2.6k 3.8×	185	15.3k
John Stover	3.4k 1.4×	763 0.4×	2.4k 1.6×	670 0.8×	120 0.2×	254	8.3k
James Wiley	1.4k 0.6×	280 0.2×	1.5k 1.0×	857 1.1×	749 1.1×	127	5.0k
William W. Darrow	1.6k 0.6×	636 0.4×	1.4k 0.9×	737 0.9×	205 0.3×	78	3.3k
Frits van Griensven	5.0k 2.0×	1.8k 1.0×	3.8k 2.5×	2.3k 2.9×	164 0.2×	159	6.9k
David J. Weber	2.1k 0.8×	349 0.2×	1.7k 1.1×	180 0.2×	1.2k 1.8×	344	12.2k
Ariane van der Straten	5.2k 2.1×	819 0.5×	2.7k 1.8×	1.7k 2.1×	227 0.3×	245	7.9k
Mark Pearson	968 0.4×	1.6k 0.9×	529 0.4×	477 0.6×	792 1.2×	143	6.9k

Countries citing papers authored by Robert Redfield

Since Specialization

Citations

This map shows the geographic impact of Robert Redfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Redfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Redfield more than expected).

Fields of papers citing papers by Robert Redfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Redfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Redfield. The network helps show where Robert Redfield may publish in the future.

Co-authorship network of co-authors of Robert Redfield

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Redfield. A scholar is included among the top collaborators of Robert Redfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Redfield. Robert Redfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prakash, Swayam, Delia F. Tifrea, Cesar Figueroa, et al.. (2025). Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID. Viruses. 17(10). 1310–1310.

Redfield, Robert, et al.. (2019). Health Care Autonomy of Women Living with HIV. New England Journal of Medicine. 381(9). 798–800. 3 indexed citations

Latinovic, Olga, Yutaka Tagaya, Alonso Heredia, et al.. (2019). Suppression of Active HIV-1 Infection in CD34 ⁺ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs. AIDS Research and Human Retroviruses. 35(8). 718–728. 8 indexed citations

Sørensen, Birger, Maja A. Sommerfelt, Peter L. Smith, et al.. (2017). Correlation of Antibody Responses to a Peptide Antigen gp120-C5 ^501–512 /gp41 ^732–744 with HIV Disease Progression. AIDS Research and Human Retroviruses. 33(6). 558–566. 3 indexed citations

Dziuban, Eric J., Evelyn Ngugi, Guoqing Zhang, et al.. (2017). High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy. The Pediatric Infectious Disease Journal. 36(8). 758–760. 4 indexed citations

Riedel, David J., et al.. (2016). Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer. AIDS Research and Human Retroviruses. 33(5). 482–489. 3 indexed citations

Heredia, Alonso, Nhut Le, Ronald B. Gartenhaus, et al.. (2015). Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice. Proceedings of the National Academy of Sciences. 112(30). 9412–9417. 79 indexed citations

Latinovic, Olga, Sandra Medina-Moreno, Neelakshi Gohain, et al.. (2015). Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies. AIDS Research and Human Retroviruses. 32(2). 178–186. 3 indexed citations

Riedel, David J., Anne F. Rositch, Robert Redfield, & William A. Blattner. (2015). HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population. Leukemia & lymphoma. 57(2). 306–312. 18 indexed citations

10.

Buchwald, Ulrike K., et al.. (2014). Influence of Transportation Cost on Long-Term Retention in Clinic for HIV Patients in Rural Haiti. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(4). e123–e130. 13 indexed citations

11.

Eyzaguirre, Lindsay M., Manhattan Charurat, Robert Redfield, et al.. (2013). Elevated hypermutation levels in HIV-1 natural viral suppressors. Virology. 443(2). 306–312. 25 indexed citations

12.

Sajadi, Mohammad M., George K. Lewis, Michael S. Seaman, et al.. (2012). Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human Plasma. Journal of Virology. 86(9). 5014–5025. 11 indexed citations

13.

Hicks, Charles B., Patrick G. Clay, Robert Redfield, et al.. (2012). Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV Type 1-Infected Subjects. AIDS Research and Human Retroviruses. 29(2). 250–255. 13 indexed citations

14.

Sajadi, Mohammad M., Rohit Talwani, Charles D. Howell, et al.. (2011). IL28B Genotype Does Not Correlate with HIV Control in African Americans. Clinical and Translational Science. 4(4). 282–284. 14 indexed citations

15.

Ross, Lisa, Richard Elion, Randall Lanier, et al.. (2009). Modulation of K65R Selection by Zidovudine Inclusion: Analysis of HIV Resistance Selection in Subjects with Virologic Failure Receiving Once-Daily Abacavir/Lamivudine/Zidovudine and Tenofovir DF (Study COL40263). AIDS Research and Human Retroviruses. 25(7). 665–672. 9 indexed citations

16.

Gilliam, Bruce L., Mohammad M. Sajadi, Anthony Amoroso, et al.. (2007). Tenofovir and Abacavir Combination Therapy: Lessons Learned from an Urban Clinic Population. AIDS Patient Care and STDs. 21(4). 240–246. 9 indexed citations

17.

Gilliam, Bruce L., Kirk M. Chan‐Tack, Roula Qaqish, et al.. (2006). Successful Treatment with Atazanavir and Lopinavir/Ritonavir Combination Therapy in Protease Inhibitor-Susceptible and Protease Inhibitor-Resistant HIV-Infected Patients. AIDS Patient Care and STDs. 20(11). 745–759. 9 indexed citations

18.

Dybul, Mark, Robert Bolan, David Condoluci, et al.. (2002). Evaluation of Initial CD4⁺T Cell Counts in Individuals with Newly Diagnosed Human Immunodeficiency Virus Infection, by Sex and Race, in Urban Settings. The Journal of Infectious Diseases. 185(12). 1818–1821. 60 indexed citations

19.

Ratto‐Kim, Silvia, Karl Sitz, Robin P. Garner, et al.. (1999). Repeated Immunization with Recombinant gp160 Human Immunodeficiency Virus (HIV) Envelope Protein in Early HIV‐1 Infection: Evaluation of the T Cell Proliferative Response. The Journal of Infectious Diseases. 179(2). 337–344. 22 indexed citations

20.

Redfield, Robert, et al.. (1963). The social uses of social science. University of Chicago Press eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact